Press Releases & Clinical Resources
FDA acceptance of double blind, randomized, placebo controlled Clinical Trial for Long Covid
.png)
Long COVID Diagnostic with Differentiation from Chronic Lyme Disease using Machine Learning and Cytokine Hubs
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection
Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning
Case Series: Maraviroc and Pravastatin as a Therapeutic Option to treat Long Covid/Post-Acute Sequelae of Covid (PASC)
.jpg)
.png)